Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis

Fukushima J Med Sci. 2002 Dec;48(2):103-10. doi: 10.5387/fms.48.103.

Abstract

Two patients with amyopathic dermatomyositis complicated by interstitial lung lesions were effectively treated with a combination of corticosteroids and cyclosporine and/or cyclophosphamide. A 48-year-old female patient was treated with pulse methylprednisolone and cyclosporine 2 months after onset of dermal symptoms. A 45-year-old male patient was treated with oral prednisolone and pulse cyclophosphamide 2 1/2 months after onset of dermal symptoms. Early evaluation of interstitial lung lesions and early extensive therapy may improve prognosis of interstitial lung lesions in patients with amyopathic dermatomyositis.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Cyclosporine / administration & dosage*
  • Dermatomyositis / complications
  • Dermatomyositis / drug therapy*
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lung Diseases, Interstitial / prevention & control*
  • Male
  • Middle Aged

Substances

  • Adrenal Cortex Hormones
  • Cyclosporine
  • Cyclophosphamide